Stable COPD Patients — Effect of Vitamin D3 on Lung Function and Exercise Tolerance in COPD Patients
Citation(s)
Afonso AS, Verhamme KM, Sturkenboom MC, Brusselle GG COPD in the general population: prevalence, incidence and survival. Respir Med. 2011 Dec;105(12):1872-84. doi: 10.1016/j.rmed.2011.06.012. Epub 2011 Aug 17.
Agusti AG COPD, a multicomponent disease: implications for management. Respir Med. 2005 Jun;99(6):670-82. Epub 2005 Jan 8. Review.
Atsou K, Chouaid C, Hejblum G Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review. BMC Med. 2011 Jan 18;9:7. doi: 10.1186/1741-7015-9-7. Review.
Barbu C, Iordache M, Man MG Inflammation in COPD: pathogenesis, local and systemic effects. Rom J Morphol Embryol. 2011;52(1):21-7. Review.
Biswas S, Hwang JW, Kirkham PA, Rahman I Pharmacological and dietary antioxidant therapies for chronic obstructive pulmonary disease. Curr Med Chem. 2013;20(12):1496-530. Review.
Black PN, Scragg R Relationship between serum 25-hydroxyvitamin d and pulmonary function in the third national health and nutrition examination survey. Chest. 2005 Dec;128(6):3792-8.
Finkelstein J, Cha E, Scharf SM Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity. Int J Chron Obstruct Pulmon Dis. 2009;4:337-49. Epub 2009 Sep 24.
Førli L, Bjortuft O, Boe J Vitamin D status in relation to nutritional depletion and muscle function in patients with advanced pulmonary disease. Exp Lung Res. 2009 Aug;35(6):524-38.
Holick MF, Chen TC Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008 Apr;87(4):1080S-6S. Review.
Ismail M, Hossain MF, Tanu AR, Shekhar HU Effect of spirulina intervention on oxidative stress, antioxidant status, and lipid profile in chronic obstructive pulmonary disease patients. Biomed Res Int. 2015;2015:486120. doi: 10.1155/2015/486120. Epub 2015 Jan 22.
Jabbari A, Tabasi S, Masrour J Vitamin D serum level and chronic obstructive lung disease. Caspian J Intern Med. 2013 Winter;4(1):624-6.
JACKSON GG, DOWLING HF, SPIESMAN IG, BOAND AV Transmission of the common cold to volunteers under controlled conditions. I. The common cold as a clinical entity. AMA Arch Intern Med. 1958 Feb;101(2):267-78.
Kendrick KR, Baxi SC, Smith RM Usefulness of the modified 0-10 Borg scale in assessing the degree of dyspnea in patients with COPD and asthma. J Emerg Nurs. 2000 Jun;26(3):216-22.
Kunisaki KM, Niewoehner DE, Singh RJ, Connett JE Vitamin D status and longitudinal lung function decline in the Lung Health Study. Eur Respir J. 2011 Feb;37(2):238-43. doi: 10.1183/09031936.00146509. Epub 2010 Jul 1.
van de Bool C, Steiner MC, Schols AM Nutritional targets to enhance exercise performance in chronic obstructive pulmonary disease. Curr Opin Clin Nutr Metab Care. 2012 Nov;15(6):553-60. doi: 10.1097/MCO.0b013e328358bdeb. Review.
Effect of Vitamin D3 on Lung Function and Exercise Tolerance in D3 Deficient COPD Patients
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
